|
|
||||||||||
Research Articles |
OBJECTIVE: To implement and evaluate pharmaceutical care services for patients with hyperlipidemias in the community pharmacy setting, to evaluate the results of a pharmaceutical care training process for pharmacists by using an assessment quiz, and to measure patient outcomes resulting from provision of pharmaceutical care to patients with hyperlipidemia. DESIGN: A prospective study was conducted over a 1-year period. Patients served as their own controls. SETTING: Two independent community pharmacies in Richmond, Virginia. PARTICIPANTS: Twenty-five adult patients with confirmed dyslipidemias completed the study. INTERVENTIONS: Study pharmacists assessed each patient and assisted in setting therapeutic goals; patients also completed a visit with a registered dietitian. Drug therapy recommendations were made to physicians by the pharmacist when appropriate. Follow-up was scheduled with the pharmacist to ensure positive outcomes and reduce adverse effects. MAIN OUTCOME MEASURES: Fasting lipoprotein profiles were measured initially and at 6 and 12 months. The SF-36 survey, the MacKeigan-Larson satisfaction survey, and a patient opinion survey were administered initially and at the conclusion of the study. RESULTS: Total cholesterol and low-density lipoprotein cholesterol values were significantly decreased at 12 months compared with either the baseline or 6-month values (p < 0.02). Significant improvement was found in several domains of the surveys; quality of life, patient satisfaction with pharmacy services, and patient opinions on the role of the pharmacist improved after the intervention. CONCLUSIONS: Pharmaceutical care may positively affect lipid values, quality of life, and patient satisfaction.
This article has been cited by other articles:
![]() |
M. Machado, N. Nassor, J. M Bajcar, G. C Guzzo, and T. R Einarson Sensitivity of Patient Outcomes to Pharmacist Interventions. Part III: Systematic Review and Meta-Analysis in Hyperlipidemia Management Ann. Pharmacother., September 1, 2008; 42(9): 1195 - 1207. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Tinelli, C. Bond, A. Blenkinsopp, M. Jaffray, M. Watson, P. Hannaford, and the Community Pharmacy Medicines Management Evalua Patient Evaluation of a Community Pharmacy Medications Management Service Ann. Pharmacother., December 1, 2007; 41(12): 1962 - 1970. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. Traverso, M. Salamano, C. Botta, M. Colautti, V. Palchik, and B. Perez Questionnaire to assess patient satisfaction with pharmaceutical care in Spanish language Int. J. Qual. Health Care, August 1, 2007; 19(4): 217 - 224. [Abstract] [Full Text] [PDF] |
||||
![]() |
The Community Pharmacy Medicines Management Projec The MEDMAN study: a randomized controlled trial of community pharmacy-led medicines management for patients with coronary heart disease Fam. Pract., April 1, 2007; 24(2): 189 - 200. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Collins, A. Kramer, M. E. O'Day, and M. B. Low Evaluation of patient and provider satisfaction with a pharmacist-managed lipid clinic in a Veterans Affairs medical center. Am. J. Health Syst. Pharm., September 15, 2006; 63(18): 1723 - 1727. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. L. Olson and L. A. Potts Role of the Pharmacist in the Management of Dyslipidemia Journal of Pharmacy Practice, April 1, 2006; 19(2): 94 - 102. [Abstract] [PDF] |
||||
![]() |
C. P Paulos, C. E A. Nygren, C. Celedon, and C. A Carcamo Impact of a Pharmaceutical Care Program in a Community Pharmacy on Patients with Dyslipidemia Ann. Pharmacother., May 1, 2005; 39(5): 939 - 943. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. T. Tsuyuki, J. A. Johnson, K. K. Teo, S. H. Simpson, M. L. Ackman, R. S. Biggs, A. Cave, W.-C. Chang, V. Dzavik, K. B. Farris, et al. A Randomized Trial of the Effect of Community Pharmacist Intervention on Cholesterol Risk Management: The Study of Cardiovascular Risk Intervention by Pharmacists (SCRIP) Arch Intern Med, May 27, 2002; 162(10): 1149 - 1155. [Abstract] [Full Text] [PDF] |
||||